Can antiplatelet therapy after drug eluting stent become a problem?
Many clinical trials demonstrate that demonstrate drug-eluting stents (DES) can improve procedural success in patients with acute coronary syndromes, with a remarkable reduction in the rate of restenosis. On the other hand, it has been shown that stenting can also increase the rate of thrombotic com...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd
2009-03-01
|
Series: | Clinical Management Issues |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/556 |